JP2008511668A5 - - Google Patents

Download PDF

Info

Publication number
JP2008511668A5
JP2008511668A5 JP2007530352A JP2007530352A JP2008511668A5 JP 2008511668 A5 JP2008511668 A5 JP 2008511668A5 JP 2007530352 A JP2007530352 A JP 2007530352A JP 2007530352 A JP2007530352 A JP 2007530352A JP 2008511668 A5 JP2008511668 A5 JP 2008511668A5
Authority
JP
Japan
Prior art keywords
methyl
imidazo
tetrahydro
pyridin
quinolinamine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007530352A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008511668A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/031098 external-priority patent/WO2006028896A2/en
Publication of JP2008511668A publication Critical patent/JP2008511668A/ja
Publication of JP2008511668A5 publication Critical patent/JP2008511668A5/ja
Pending legal-status Critical Current

Links

JP2007530352A 2004-09-02 2005-08-31 化合物 Pending JP2008511668A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US60674204P 2004-09-02 2004-09-02
US61076504P 2004-09-17 2004-09-17
PCT/US2005/031098 WO2006028896A2 (en) 2004-09-02 2005-08-31 Chemical compounds

Publications (2)

Publication Number Publication Date
JP2008511668A JP2008511668A (ja) 2008-04-17
JP2008511668A5 true JP2008511668A5 (https=) 2008-10-16

Family

ID=36000724

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2007530353A Pending JP2008511669A (ja) 2004-09-02 2005-08-28 化合物
JP2007530352A Pending JP2008511668A (ja) 2004-09-02 2005-08-31 化合物

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2007530353A Pending JP2008511669A (ja) 2004-09-02 2005-08-28 化合物

Country Status (16)

Country Link
US (2) US20070232615A1 (https=)
EP (2) EP1799671A4 (https=)
JP (2) JP2008511669A (https=)
KR (2) KR20070053313A (https=)
AR (2) AR051565A1 (https=)
AU (2) AU2005279835A1 (https=)
BR (1) BRPI0514881A (https=)
CA (2) CA2578746A1 (https=)
IL (1) IL181419A0 (https=)
MA (1) MA28872B1 (https=)
MX (2) MX2007002679A (https=)
NO (2) NO20071366L (https=)
PE (2) PE20060656A1 (https=)
RU (2) RU2352567C2 (https=)
TW (2) TW200621754A (https=)
WO (2) WO2006026703A2 (https=)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2007002679A (es) * 2004-09-02 2007-05-16 Smithkline Beecham Corp Compuestos quimicos.
PE20070946A1 (es) * 2006-01-25 2007-10-16 Smithkline Beecham Corp COMPUESTOS DERIVADOS DE IMIDAZO[1,2-a]PIRIDINA COMO MODULADORES DEL RECEPTOR DE QUIMIOQUINA (CXCR4)
WO2007132846A1 (ja) 2006-05-16 2007-11-22 Ono Pharmaceutical Co., Ltd. 保護されていてもよい酸性基を含有する化合物およびその用途
JP5245827B2 (ja) 2006-07-31 2013-07-24 小野薬品工業株式会社 スピロ結合した環状基を含有する化合物およびその用途
US7767826B2 (en) * 2007-10-05 2010-08-03 Pharmatech International, Inc. Process for the synthesis of L-(+)-ergothioneine
EP2217069A4 (en) * 2007-11-09 2012-03-14 Salk Inst For Biological Studi INHIBITORS OF NON-NUCLEOSIDE INHIBITORS OF THE REVERSE TRANSCRIPTASE
CN102675305B (zh) * 2011-03-08 2014-11-12 中国科学院上海药物研究所 一类咪唑并吡啶类化合物及其制备方法和用途
CN103570683B (zh) * 2012-07-30 2018-04-17 中国科学院上海药物研究所 多取代胺类化合物及其制备方法和用途
JP6602779B2 (ja) 2014-02-13 2019-11-06 インサイト・コーポレイション Ｌｓｄ１阻害剤としてのシクロプロピルアミン類
EP3105218B1 (en) 2014-02-13 2019-09-25 Incyte Corporation Cyclopropylamines as lsd1 inhibitors
US9695167B2 (en) 2014-07-10 2017-07-04 Incyte Corporation Substituted triazolo[1,5-a]pyridines and triazolo[1,5-a]pyrazines as LSD1 inhibitors
EP3277689B1 (en) * 2015-04-03 2019-09-04 Incyte Corporation Heterocyclic compounds as lsd1 inhibitors
MY189367A (en) 2015-08-12 2022-02-08 Incyte Corp Salts of an lsd1 inhibitor
CA3008279A1 (en) 2015-12-14 2017-06-22 X4 Pharmaceuticals, Inc. Methods for treating cancer
CN109069426B (zh) 2015-12-14 2021-10-29 X4 制药有限公司 治疗癌症的方法
JP6856648B2 (ja) * 2015-12-15 2021-04-07 ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ Ｃｘｃｒ４受容体アンタゴニスト
WO2017112894A1 (en) 2015-12-22 2017-06-29 X4 Pharmaceuticals, Inc. Methods for treating immunodeficiency disease
CA3019394A1 (en) 2016-04-08 2017-10-12 X4 Pharmaceuticals, Inc. Methods for treating cancer
EP3472129A4 (en) 2016-06-21 2019-12-04 X4 Pharmaceuticals, Inc. CXCR4 INHIBITORS AND USES THEREOF
CN109640988A (zh) 2016-06-21 2019-04-16 X4 制药有限公司 Cxcr4抑制剂及其用途
ES2870920T3 (es) 2016-06-21 2021-10-28 X4 Pharmaceuticals Inc Inhibidores de CXCR4 y usos de los mismos
AU2018225556A1 (en) 2017-02-21 2019-10-03 Emory University Chemokine CXCR4 receptor modulators and uses related thereto
JP7282786B2 (ja) * 2017-09-25 2023-05-29 シージーンテック （スーチョウ， チャイナ） カンパニー リミテッド Ｃｘｃｒ４阻害剤としてのヘテロアリール化合物、それを用いた組成物及び方法
WO2019060860A1 (en) * 2017-09-25 2019-03-28 Suzhou Yunxuan Yiyao Keji Youxian Gongsi HETEROARYL COMPOUNDS AS INHIBITORS OF CXCR4, COMPOSITION AND METHOD OF USE THEREOF
US11649235B2 (en) 2018-03-19 2023-05-16 Emory University Pan-tropic entry inhibitors
US10968200B2 (en) 2018-08-31 2021-04-06 Incyte Corporation Salts of an LSD1 inhibitor and processes for preparing the same
US10548889B1 (en) 2018-08-31 2020-02-04 X4 Pharmaceuticals, Inc. Compositions of CXCR4 inhibitors and methods of preparation and use
CA3171250A1 (en) 2020-03-10 2021-09-16 E. Lynne KELLEY Methods for treating neutropenia

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ225152A (en) * 1987-07-17 1990-04-26 Janssen Pharmaceutica Nv Heterocyclically substituted piperidinyl benzamides as pharmaceuticals
US6734191B2 (en) * 2000-09-15 2004-05-11 Anormed, Inc. Chemokine receptor binding heterocyclic compounds
HK1052011A1 (zh) * 2000-09-15 2003-08-29 Anormed Inc. 趋化因子受体结合杂环化合物
JP2004512336A (ja) * 2000-09-15 2004-04-22 アノーメッド　インコーポレイティド ケモカインレセプター結合複素環式化合物
DE60137435D1 (de) * 2000-09-15 2009-03-05 Anormed Inc Chemokin rezeptor bindenden heterozyklische verbindungen
PL369856A1 (en) * 2001-12-21 2005-05-02 Anormed Inc. Chemokine receptor binding heterocyclic compounds with enhanced efficacy
WO2004091518A2 (en) * 2003-04-11 2004-10-28 Anormed Inc. Cxcr4 chemokine receptor binding compounds
MX2007002679A (es) * 2004-09-02 2007-05-16 Smithkline Beecham Corp Compuestos quimicos.
WO2006036816A2 (en) * 2004-09-24 2006-04-06 Smithkline Beecham Corporation Chemical compounds
JP2009507795A (ja) * 2005-08-31 2009-02-26 スミスクライン ビーチャム コーポレーション 化合物

Similar Documents

Publication Publication Date Title
JP2008511668A5 (https=)
RU2351592C2 (ru) Производные тетрагидрохинолина и фармацевтическая композиция на их основе для лечения и профилактики вич-инфекции
JP2008510006A5 (https=)
JP2008511669A5 (https=)
RU2632900C2 (ru) Гетероциклические амины и их применение
CA2228370C (en) Piperazino derivatives as neurokinin antagonists
RU2486188C2 (ru) СОЕДИНЕНИЯ ИМИДАЗО-[1,2-b]-ПИРИДАЗИНА (ВАРИАНТЫ), СПОСОБ ПОЛУЧЕНИЯ СОЕДИНЕНИЙ ИМИДАЗО-[1,2-b]-ПИРИДАЗИНА (ВАРИАНТЫ), ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ И ЛЕКАРСТВЕННОЕ СРЕДСТВО ДЛЯ ЛЕЧЕНИЯ И/ИЛИ ПРЕДУПРЕЖДЕНИЯ ЗАБОЛЕВАНИЙ, СВЯЗАННЫХ С ИНГИБИРОВАНИЕМ ГАМКА РЕЦЕПТОРОВ
RU2435770C2 (ru) ЗАМЕЩЕННЫЕ БИЦИКЛИЧЕСКИЕ ИМИДАЗО-3-ИЛАМИНЫ, ПРИГОДНЫЕ ДЛЯ РЕГУЛЯЦИИ mGluR5-РЕЦЕПТОРА
RU2004117156A (ru) Амид замещенные имидазопиридины
RS60312B1 (sr) Jedinjenja indol karboksamida korisna kao inhibitori kinaze
US20030191143A1 (en) Fused heterocyclic compounds and use thereof
TW201819386A (zh) Shp2磷酸酶抑制劑及其使用方法
RU2015106787A (ru) Замещенные пирролы, активные в качестве ингибиторов киназ
RU2004106783A (ru) Производные 4-амино-6-фенилпирроло[2, 3] пиримидина
JP2005511745A5 (https=)
JP2008525502A (ja) 抗炎症薬
JP2004511483A (ja) Ｈｉｖインテグラーゼ阻害薬として有用なアザ−およびポリアザ−ナフタレニルカルボキサミド類
CN103936690A (zh) 氨基二氢噻嗪衍生物
RU2005136130A (ru) Новые антагонисты р2х7 рецепторов и их применение
KR20090106604A (ko) 축합 피리딘 화합물
JP2008509187A5 (https=)
JP2005524609A5 (https=)
RS59707B1 (sr) Derivati karbazola
JP2023529099A (ja) 修飾タンパク質およびタンパク質分解誘導薬
JP2022534434A5 (https=)